ADMA News and Press, ADMA Biologics Inc From 01/29/21

We are trying something new this year where we share and track the 2021 Top Ideas from our Marketplace contributors. We start off with our Tech/Growth and Value stock contributors and highlight two picks that quickly peaked with 70% returns in under two weeks. Next week, we'll sha...

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the Centers for Medicare...

welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report.Monda...

Analysts Are Bullish On These Penny Stocks What do you look for when it comes to finding the best penny stocks to buy ? Are you looking for technical set-ups, or are you searching for news catalysts? You may even be looking to find cheap stocks for your watch list. Another way trade...

In its prelim Q4 prelim update, ADMA Biologics ([[ADMA]] +9.2%) reported $13.9M (+16% Y/Y) in total revenues (highest revenue quarter since inception); FY20 total revenues seen at $42.2M (+44% Y/Y)."2021 is poised to be a transformative year for ADMA as we continue to execute on our mission o...

Achieved Fourth Quarter 2020 Preliminary Unaudited Total Revenues of $13.9 Million, the Highest Revenue Quarter for the Company Since Inception Full Year 2020 Preliminary Unaudited Total Revenues of $42.2 Million, a 44% Increase Over Full Year 2019 Multiple Value-Creating FDA Deci...

We continue our Roundtable series with Part 2 - General Outlook. 2020 was a challenging year in many ways - the markets shrugged off the record drop in March and ended the year with new highs. 2021 brings us more uncertainty. Our Marketplace contributors offer their thoughts. ...

ADMA has been overly chastised by the market, and its business is performing very well. At its current trading level, ADMA is trading at just about its enterprise value when considering the value of its portfolio of plasma collection centers, which will soon be 16. Strong insider ...

Are These Penny Stocks To Buy Or Avoid Right Now? While Monday, January 4th was an overall rough day for the stock market, there were plenty of penny stocks making big gains. During the trading day, companies from a wide array of industries shot up in value. Now, this occurred for a...

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the Centers for Medicare...